150 related articles for article (PubMed ID: 27832471)
1. Expression pattern of BCCIP in hepatocellular carcinoma is correlated with poor prognosis and enhanced cell proliferation.
Lin Z; Hu B; Ni W; Mao X; Zhou H; Lv J; Yin B; Shen Z; Wu M; Ding W; Xiao M; Ni R
Tumour Biol; 2016 Nov; ():. PubMed ID: 27832471
[TBL] [Abstract][Full Text] [Related]
2. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
[TBL] [Abstract][Full Text] [Related]
3. BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1.
Meng X; Lu H; Shen Z
Cell Cycle; 2004 Nov; 3(11):1457-62. PubMed ID: 15539944
[TBL] [Abstract][Full Text] [Related]
4. BCCIP is required for the nuclear localization of the p21 protein.
Fan J; Wray J; Meng X; Shen Z
Cell Cycle; 2009 Sep; 8(18):3019-24. PubMed ID: 19713748
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of G1 to S cell cycle progression by BCCIP beta.
Meng X; Liu J; Shen Z
Cell Cycle; 2004 Mar; 3(3):343-8. PubMed ID: 14726710
[TBL] [Abstract][Full Text] [Related]
6. YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21
Sui Y; Wu T; Li F; Wang F; Cai Y; Jin J
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035388
[TBL] [Abstract][Full Text] [Related]
7. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.
Liu J; Lu H; Ohgaki H; Merlo A; Shen Z
BMC Cancer; 2009 Aug; 9():268. PubMed ID: 19653894
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP.
Xu XT; Hu WT; Zhou JY; Tu Y
Am J Transl Res; 2017; 9(3):1088-1100. PubMed ID: 28386336
[TBL] [Abstract][Full Text] [Related]
9. Roles of BCCIP deficiency in mammary tumorigenesis.
Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
[TBL] [Abstract][Full Text] [Related]
11. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J
Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408
[TBL] [Abstract][Full Text] [Related]
12. Expression and Significance of BCCIP and Glutathione Peroxidase 4 in Clear Cell Renal Cell Carcinoma.
Liu Y; Liu J; Liu C; Jin J; Liu Y
Bull Exp Biol Med; 2024 Jan; 176(3):363-368. PubMed ID: 38342812
[TBL] [Abstract][Full Text] [Related]
13. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
14. BCCIP as a prognostic marker for radiotherapy of laryngeal cancer.
Rewari A; Lu H; Parikh R; Yang Q; Shen Z; Haffty BG
Radiother Oncol; 2009 Feb; 90(2):183-8. PubMed ID: 19046788
[TBL] [Abstract][Full Text] [Related]
15. Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.
Zhang MF; Zhang ZY; Fu J; Yang YF; Yun JP
J Transl Med; 2009 Dec; 7():110. PubMed ID: 20025780
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
17. Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma.
Shi W; Huang W; Chen Y; Zhang S; Xu P; Gu X; Fan H; Xu J; Chen Y; Ni R; Lu C; Zhang X
Tumour Biol; 2016 Aug; 37(8):10447-57. PubMed ID: 26846109
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
19. Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.
Su J; Sui Y; Ding J; Li F; Shen S; Yang Y; Lu Z; Wang F; Cao L; Liu X; Jin J; Cai Y
Protein Cell; 2016 Oct; 7(10):749-760. PubMed ID: 27535137
[TBL] [Abstract][Full Text] [Related]
20. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
